Read + Share
Amedeo Smart
Independent Medical Education
Alexeev SM, Khorinko AV, Mukhametshina GZ, Shelepen KG, et al. Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab. BMC Cancer 2020;20:783.PMID: 32819305
Email
LinkedIn
Facebook
Twitter
Privacy Policy